← Evidence map

TrialPharmacology research & perspectives2024

Evaluation of OCT2-mediated drug-drug interactions between ulotaront and metformin in subjects with schizophrenia.

Guangqing Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38527949